期刊文献+

免疫组织化学染色在食管梭形细胞肿瘤诊断中的应用 被引量:3

Application of immunohistochemical staining in diagnosis of esophageal spindle cell tumor
暂未订购
导出
摘要 目的:探讨免疫组织化学染色在食管梭形细胞肿瘤鉴别诊断及明确肿瘤的来源的意义。方法:应用HE染色及免疫组织化学染色法,检测18例食管梭形细胞肿瘤标本CD117、CD34、SMA、Desmin和S-100抗体的表达。结果:18例食管梭形细胞肿瘤中CD34、S-100、Desmin的阳性/阴性表达比例分别为4/14、0/18和12/6。CD117:6例阳性,其中2例局部胞膜阳性细胞,4例梭形细胞胞质阳性;12例阴性。SMA:17例肿瘤细胞呈程度不等的弥漫阳性。18例食管梭形细胞肿瘤中12例为平滑肌瘤,6例为间质瘤。结论:免疫组织化学技术能比较准确地判断食管梭形细胞肿瘤的生物学行为和预后,为术后合理选择分子靶向治疗方案提供方向。 Objective To investigate the significance of immunohistochemical method in differential diagnosis and definiting the origin of esophageal spindle cell tumors.Methods Eighteen cases of esophageal stromal turmors were studied by HE staning and immunohistochemistry to detect the expressions of CD117,CD34,SMA,Desmin and S-100.Results In 18cases of esophageal spindle cell tumors,the CD34,S-100,Desmin positive/negative expression rates were 4/14,0/18and 12/6,respectively.6cases of esophageal spindle cell tumors were positive for CD117,among them 2cases were local positive in membrane and 4cases were positive in cytoplasm of spindle cells. 12cases of esophageal spindle cell tumors were negative for CD117.17cases tumor cells were varying degrees diffusely and positive expression for SMA.Among 18cases of esophageal spindle cell tumors,12cases were leiomyoma and 6cases were gastrointestinal stromal tumors.Conclusion Immunohistochemistry could accurately determine the biological behavior and prognosis of esophageal spindle cell tumors,it could provide direction for reasonable choice of molecular target therapy after operation.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2010年第5期962-964,F0003,共4页 Journal of Jilin University:Medicine Edition
基金 吉林省科技厅科研基金资助课题(200505220)
关键词 免疫组织化学染色 食管肿瘤 梭形细胞 immunohistochemical staining esophageal neoplasms spindle cell
  • 相关文献

参考文献10

  • 1Lewin K J, Appleman HD. Tumors of the esophagus and stomach. Atlas of tumor Pathology [M]. Washington DC: AFIP, 1996: 151.
  • 2Markku M, Maait SR, Leslie H, et al. Esophageal stromal tumors : aclinicopathologic, immunohistochemical and molecular genetic study of 17 cases and comparision with esophageal leiomyomas and leiomyosarcomas [J]. Am J Surg Pathol, 2000, 24 (2): 211-222.
  • 3Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis [J]. AmJ Surg Pathol, 1983, 7 (6): 507-519.
  • 4Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach : clinicopathologic,imrnunohistochemical, and molecular genetic study of 1765 cases with long term follow-up [J]. Am J Surg Pathol, 2005, 29 (1): 52-68.
  • 5马大烈,刘晓红,白辰光,吴丽莉,谢强.食管间质瘤的临床病理及免疫组织化学研究[J].中华外科杂志,2002,40(3):237-237. 被引量:18
  • 6刘星,卢辉山,蒋伟忠.原发性胃肠间质肿瘤121例临床分析[J].肿瘤,2009,29(9):879-883. 被引量:3
  • 7Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach [J]. Hum Pathol, 2002, 33 (5): 459-465.
  • 8Sarloma RM, Kovatich AJ, Barusevicuis A, et al. CD117:a sensitive marker for gastrointestinal stromal tumors that is more specificthan CD34 [J]. Mod Pathol, 1998, 11 (8): 728-734.
  • 9Heinrich MC, Rubin BP, Longley B, et al. Biology and genetics aspects of gastrointestinal stromal tumors. KIT activation and cytogeneticalterations [J]. Hum Pathol, 2002, 33 (5): 484- 495.
  • 10黄芪,刘先玲.胃肠道间质瘤的研究进展[J].重庆医学,2009,38(6):726-728. 被引量:5

二级参考文献13

  • 1黄文斌,陈洁宇,周晓军.PKCθ:一个新的诊断胃肠道间质肿瘤(GIST),特别是KIT阴性表达的GIST的免疫组化标记物[J].临床与实验病理学杂志,2005,21(4):441-441. 被引量:20
  • 2黄海,王仆,刘岩雪,战忠利,梁寒.与胃间质瘤恶性程度相关的临床病理和免疫组化研究[J].肿瘤,2006,26(10):927-929. 被引量:1
  • 3徐守余,杨道华,邱承敏,张鸣,何佩锋,柳堤.胃肠道间质瘤24例临床病理及免疫组化分析[J].肿瘤,2007,27(6):473-475. 被引量:4
  • 4MAZUR M T, CLARK H B. Gastric stromal tumors: reappraisal of histogcnsis[ J]. Am J Surg Pathol, 1983, 7(6) :507-519.
  • 5FLETCHER CD, BERMAN J J, CORLESS C, et al. Diagnosis of gastro-intestinal stromal tumors: a consensus approach[ J]. Hum Pathol, 2002, 3 (5) :459 465.
  • 6GOMES A L, BARDALES R H, MILANEZI F, et al. Molecular analysis of c-Kit and PDGFRA in GISTs diagnosed by EUS [ J ]. Am J Clin Pathol, 2007, 127( 1 ) :89-96.
  • 7OROSZ Z, TORNOCZKY T, SAPI Z. Gastrointestinal stromal tumor: a clinicopathologic and immunohistochemical study of 136 cases[J]. Pathol Oncol Res, 2005, 11 ( 1 ) :12-21.
  • 8MIETTINEN M, SOBIN LH, LASOTA J. Gastrointestinal stromal tumors of the stomach : a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up [J]. Am J Surg Pathol, 2005, 29(10) :52-68.
  • 9DEMATTEO R P, SHAH A, FANG Y, et al. Results of hepatic resection for sarcoma metastatic to liver[ J]. Ann Surg, 2001,234 (4) :540-547.
  • 10DMATTEO RP, OWZAR K, MAKI R, et al. Adjuvant imatinib mesylate increases recurrence free suvival (RFS) in patients with completely resected localized primary gastrointestinal stromal tumor (GIST): North American Intergroup phase III trial ACOSO G Z9001 [ J ]. J Clin Olwol, 2007, 25 ( S18 ) : A10079.

共引文献23

同被引文献24

  • 1胡振东,许林,曲渊.20例食管癌肉瘤的诊断与治疗分析[J].肿瘤,2004,24(6):601-602. 被引量:8
  • 2马心健,崔广德,李振龙,王超峰,马震.食管癌肉瘤11例[J].菏泽医学专科学校学报,2002,14(1):18-19. 被引量:4
  • 3冯庆来,尚淑艳,赵锡江.胸段食管癌淋巴结转移规律的探讨[J].中国肿瘤临床,2005,32(12):706-708. 被引量:53
  • 4季小龙.消化病理学[M].北京:人民军医出版社,2010:274-275.
  • 5Iwaya TMaesawa C, Tamura G, et al. Esophageal carcinoma sar- coma genetic analysis [J].Gastroentrology,1997,113(3) :973.
  • 6Iascone C, Barreca M. Carcinoma and pseudosarcoma of the e- sophagus., two names, one disease : comprehensive of the literature [J]. WorId J surg,1999,23:153.
  • 7Ota S,Kato A,kobayashi H,et al. Monoclonal origin of an esoph- ageal carcinosarcoma producing Granulocytecolony stimulating factor [J]. cancer,1999,82(11) :2012.
  • 8纪小龙.消化道病理学[M]{H}北京:人民军医出版社,2010274-275.
  • 9Iwaya T,Maesawa C,Tamura G. Esophageal car-cinosarcoma:a genetic analysis[J].Gastroentrol,1997,(03):973-977.
  • 10Iascone C,Barreca M. Carcinosarcoma and pseudosarcoma of the esophagus:two names,one disease--comprehensive review of the literature[J].{H}WORLD Journal OF SURGERY,1999,(02):153-157.

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部